Glycanostics have been awarded a Seal of Excellence under the EIC Transition scheme to continue with its development of diagnostic tests for breast, lung and pancreatic cancers

Applications that meet all the criteria but are not recommended for funding due to budget limitations will be awarded a Seal of Excellence to help them secure funding from other sources. Companies with a Seal of Excellence can also gain support from EIC Business Acceleration Services.

EIC Transition.  The EIC Accelerator is a European Innovation Council (EIC) financial scheme. It funds innovative activities that go beyond the experimental proof of principle in laboratory to support both:

– the maturation and validation of your novel technology in the lab and in relevant application  environments

– the development of a business case and (business) model towards the innovation’s future commercialisation.

Grants of up to €2.5 million and more are available to validate and demonstrate technology in application-relevant environments and develop market readiness.